References
1. Craven V, Hausdorff WP, Everard ML. High levels of inherent variability in microbiological assessment of bronchoalveolar lavage samples from children with persistent bacterial bronchitis and healthy controls. Pediatric pulmonology 2020.
2. Denton M, Doherty C, Foweraker J, et al. Laboratory standards for processing microbiological samples from people with cystic fibrosis.Cystic Fibrosis Trust; Report of the UK Cystic Fibrosis Trust Microbiology Laboratory Standards Working Group: Kent, UK 2010.
3. Salter SJ, Cox MJ, Turek EM, et al. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses.BMC biology 2014; 12 : 87.
4. Hare KM, Pizzutto SJ, Chang AB, et al. Defining lower airway bacterial infection in children with chronic endobronchial disorders.Pediatric pulmonology 2018; 53 (2): 224-32.
5. Rosenow T, Mok LC, Turkovic L, et al. The cumulative effect of inflammation and infection on structural lung disease in early cystic fibrosis. The European respiratory journal 2019; 54 (1).
6. Frayman KB, Armstrong DS, Carzino R, et al. The lower airway microbiota in early cystic fibrosis lung disease: a longitudinal analysis. Thorax 2017; 72 (12): 1104-12.